Spontaneous Occurrence of Symptomatic Paroxysmal Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia in Untreated Patients

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Circulation

• Publication date

  1993-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.87.4.1114PMID 8462140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical cardiac electrophysiology ; techniques and interpretations

  2001cited by this paper
• Treatment of paroxysmal supraventricular tachycardia with oral diltiazem

  1992cited by this paper
• Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.

  1991cited by this paper
• Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation.

  1991cited by this paper
• Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.

  1991cited by this paper
• Clinical Performance of the Implantable Cardioverter Defibrillator: Electrocardiographic Documentation of 101 Spontaneous Discharges

  1991cited by this paper
• Cardiac Electrophysiology: From Cell to Bedside

  1990cited by this paper
• Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.

  1989cited by this paper
• Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation.

  1989cited by this paper
• Circadian occurrence of symptomatic paroxysmal supraventricular tachycardia in untreated patients.

  1988cited by this paper
• Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia.

  1986cited by this paper
• Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia.

  1986cited by this paper
• The spontaneous occurrence of paroxysmal supraventricular tachycardia.

  1984cited by this paper
• Electrocardiogram recording by telephone in antiarrhythmic drug trials.

  1982cited by this paper
• Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome.

  1981cited by this paper
• Atrial fibrillation in the preexcitation syndrome.

  1977cited by this paper
• Mechanisms of Spontaneous Alternation between Reciprocating Tachycardia and Atrial Flutter- Fibrillation in the Wolff‐Parkinson‐White Syndrome

  1977cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper
• Atrial fibrillation in the Wolff-Parkinson-White syndrome.

  1973cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Temporal phenotyping of paroxysmal atrial fibrillation reveals prognostic circadian subtypes

  2026cites this paper
• Spiral defect chaos with intermittency increases mean termination time.

  2025cites this paper
• Circadian patterns of atrial fibrillation and disease progression assessed by implanted loop recorders.

  2025cites this paper
• Theoretical and Practical Aspects of the Nonlinear Dynamics’ Methods of Heart Rate Variability Analyses in Tachyarrhythmia Patients Underwent Radiofrequency Catheter Ablation

  2025cites this paper
• Circadian Regulation of Cardiac Arrhythmias and Electrophysiology

  2024cites this paper
• Symptomatic or Asymptomatic Atrial Arrhythmias: Should that Change Management?

  2024cites this paper
• The relationship between morning blood pressure surge and asymptomatic episodes of paroxysmal atrial fibrillation in patients with systemic arterial hypertension

  2022cites this paper
• Diurnal circadian variations in paroxysmal atrial fibrillation: The atherosclerosis risk in communities (ARIC) study.

  2020cites this paper
• Epicardial Ablation of Supraventricular Tachycardias.

  2020cites this paper
• Circadian Rhythms and Seasonal Incidence of Cardiac Arrhythmia in Cardiovascular Patients

  2019cites this paper
• Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia.

  2019cites this paper
• Atrial fibrillation.

  2019cites this paper
• Circadian rhythm of cardiac electrophysiology, arrhythmogenesis, and the underlying mechanisms

  2019cites this paper
• Fibrillation auriculaire

  2018cites this paper
• Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden

  2018cites this paper
• Editorial

  2018cites this paper
• Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis

  2017influential citation
• European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

  2017cites this paper
• Atrial Fibrillation Symptoms and Sex, Race, and Psychological Distress: A Literature Review

  2017cites this paper
• Clusters, Gaps, and Randomness: Vasovagal Syncope Recurrence Patterns.

  2017cites this paper
• European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

  2016cites this paper
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cites this paper
• The circadian variation of premature atrial contractions.

  2016cites this paper
• 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cites this paper
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cites this paper
• Prediction of atrial fibrillation in patients with supraventricular tachyarrhythmias treated with catheter ablation or not. Classical scores are not useful.

  2016cites this paper
• 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cites this paper
• 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2016cites this paper
• İnvaziv Olmayan Ventilasyon Kullanan Kronik Solunum Yetersizlikli Kifoskolyoz Hastalarının Kardiyak Fonksiyonlarının ve Total Mortalitenin Değerlendirilmesi ÖZET

  2015cites this paper
• Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study

  2015cites this paper
• The infant with supraventricular tachycardia: Diagnosis and management

  2013cites this paper
• Relationship Between CHADS 2 Score and Efficacy of Antiarrhythmic Drug Therapy in Patients With Paroxysmal Atrial Fibrillation

  2013cites this paper
• Delayed right atrial lateral electromechanical coupling relative to the septal one can be associated with paroxysmal atrial fibrillation.

  2013cites this paper
• Prevalence of Stroke among Patients with Paroxysmal Supraventricular Tachycardia

  2013cites this paper
• Relationship between CHADS2 score and efficacy of antiarrhythmic drug therapy in patients with paroxysmal atrial fibrillation.

  2013cites this paper
• Prevalence of atrial fibrillation in patients with history of paroxysmal supraventricular tachycardia.

  2013cites this paper
• Simulation of monitoring strategies for atrial arrhythmia detection.

  2013cites this paper
• Role of Stress in Cardiac Arrhythmias.

  2013cites this paper
• Nocturnal Peak in Atrial Tachyarrhythmia Occurrence as a Function of Arrhythmia Burden

  2012cites this paper
• Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation

  2012cites this paper
• Daily distribution of atrial arrhythmic episodes in sick sinus syndrome patients: implications for atrial arrhythmia monitoring.

  2012cites this paper
• Simulation of monitoring strategies for atrial fibrillation detection

  2010cites this paper
• Simulation of daily ECG monitoring strategies for atrial fibrillation patients

  2010cites this paper
• Tachycardie de la jonction auriculoventriculaire

  2010cites this paper
• Circadian Distribution of Paroxysmal Atrial Fibrillation in Patients with and without Structural Heart Disease in Untreated State

  2009cites this paper
• Temporal distribution of atrial arrhythmic episodes

  2009cites this paper
• Clinical and electrophysiological characteristics, and relatively benign outcome, of typical atrioventricular nodal reentrant tachycardia in children and adolescents

  2008cites this paper
• Insight into the Pathophysiology of Atrial Flutter and Its Relationship to Atrial Fibrillation

  2008cites this paper
• Circadian Distribution and Autonomic Tone Modulation in Paroxysmal Atrial Fibrillation

  2008cites this paper
• Clinical characteristics and management of paroxysmal junctional tachycardia in the elderly.

  2008cites this paper
• Supraventricular tachycardia--part I.

  2008cites this paper
• Supraventricular Tachycardia and the Struggle to be Believed

  2007cites this paper
• Self-limited bursts of atrial fibrillation following successful cardioversion.

  2007cites this paper
• Efficacy of Long‐term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation —Analysis Based on Time of Onset—

  2006cites this paper
• Outcomes of Patients with Successfully Converted Paroxysmal Supraventricular Tachycardia after Four Hours of Observation in an Emergency Department of a District Hospital in Hong Kong

  2006cites this paper
• Regular supraventricular tachycardias associated with idiopathic atrial fibrillation.

  2006cites this paper
• Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients.

  2005cites this paper
• [Remote catamnesis of paroxysmal supraventricular arrhythmias which debuted in childhood].

  2005cites this paper
• Lessons Learnt from Multisite Pacing for AF Management—Technical Challenges

  2004cites this paper
• Rhythm control in atrial fibrillation: endpoints for device-based trials.

  2004cites this paper
• Pregnancy in patients with obstructive lesions: Aortic stenosis, coarctation of the aorta and mitral stenosis

  2004cites this paper
• Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.

  2003cites this paper
• Time to first recurrence as a trial endpoint: time to change?

  2003cites this paper
• Asymptomatic or “Silent” Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide

  2003cites this paper
• Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU

  2003cites this paper
• Clinical and electrophysiological characteristics in patients with atrioventricular reentrant and atrioventricular nodal reentrant tachycardia.

  2003cites this paper
• Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.

  2003cites this paper
• Spontanaktivität und Provokation fokaler Trigger bei paroxysmalem Vorhofflimmern und deren Bedeutung für die kurative Katheterablation

  2003cites this paper
• Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation.

  2003cites this paper
• Evaluation of asymptomatic and symptomatic paroxysmal atrial fibrillation using telephone transmission of electrocardiogram in patients receiving tolerating antiarrhythmic therapy

  2002cites this paper
• Early versus Late Atrial Fibrillation after Atrial Flutter Ablation

  2002cites this paper
• Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.

  2002cites this paper
• Fibrillation auriculaire

  2002cites this paper
• Aus der Medizinischen Klinik und Poliklinik I der

  2002cites this paper
• Frequent and Prolonged Asymptomatic Episodes of Paroxysmal Atrial Fibrillation Revealed by Automatic Long‐Term Event Recorders in Patients with a Negative 24‐Hour Holter

  2002cites this paper
• When is intracardiac electrophysiologic evaluation indicated in the older or very elderly patient? Complications rates and data.

  2002cites this paper
• Modeling Temporal Patterns of Atrial Tachyarrhythmias: A New Surrogate Outcome Measure for Clinical Studies?

  2002cites this paper
• Tachycardie de la jonction auriculoventriculaire

  2001cites this paper
• Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system.

  2001cites this paper
• 臨床 発症時間帯からみた発作性心房細動に対するdisopyramideの停止効果・長期予防効果

  2001cites this paper
• Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients

  2001cites this paper
• Circadian variation of paroxysmal atrial fibrillation. PA3 Investigators. Atrial Pacing Peri-ablation for Prevention of Atrial Fibrillation Trial.

  2001cites this paper
• Paroxysmal supraventricular tachycardia: outcome after ED care.

  2001cites this paper
• Circadian variation of paroxysmal atrial fibrillation

  2001cites this paper
• Circadian Rhythm and Environmental Determinants of Blood Pressure Regulation in Normal and Hypertensive Conditions

  2001cites this paper
• [Efficacy of pilsicainide for the long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].

  2001cites this paper
• Efficacy and safety of catheter ablation in octogenarians.

  2000cites this paper
• Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation.

  2000cites this paper
• Evaluation of Patients with Palpitations: Cardiac Event Recorder Versus 48‐hour Holter Monitoring

  2000cites this paper
• Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter.

  2000cites this paper
• Evaluation of the bias in using the time to the first event when the inter-event intervals have a Weibull distribution.

  1999cites this paper
• Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes.

  1999cites this paper
• ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for P

  1999cites this paper
• From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events.

  1999cites this paper
• The various forms of clinical research concerning paroxysmal atrial fibrillation.

  1999cites this paper
• ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for Ambulatory Electrocardiography

  1999cites this paper
• [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].

  1999cites this paper
• Die medikamentöse Anfallsprophylaxe bei symptomatischem paroxysmalem Vorhofflimmern/-flattern Ziele und Design der SOPAT-Studie

  1999cites this paper
• Cardiac pacing for prevention of vasovagal syncope.

  1999cites this paper
• Paroxysmal supraventricular tachycardia in the general population.

  1998cites this paper